Janssen Alzheimer Immunotherapy Research & Development, LLC

South San Francisco, USA jnj.com

Overview

Janssen Alzheimer Immunotherapy Research & Development, LLC focuses on the research and development of therapeutic solutions for Alzheimer's disease. It is a subsidiary of Johnson & Johnson, a leading global healthcare company.

Therapeutic areas

NeurologyImmunotherapy

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Janssen Alzheimer Immunotherapy Research & Development, LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

3D Imaging Drug Design and Development LLC
United States
A&B Pharmaceuticals
United States
ABC Biopharmaceuticals, Inc.
United States
ABX Pharmaceuticals Inc.
USA
AC Biotech Incorporated
USA
Accendatech USA Inc.
United States
ActiPharma Incorporated
United States
AD Pharmaceuticals Inc.
USA

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo